Boryung

KRX-003850
Korea Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#13683
Country Rank
#344
Market Cap
509.92 M
Price
6.15
Change (%)
4.49%
Volume
228,176

KRX-003850's Next Dividend

Next Estimated Amount
₩105
Next Estimated Pay Date
05/05/2026
Last Amount
₩100
Last Pay Date
04/30/2025
Dividend Shot Clock Ex-Date: 12/27/2024
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Boryung Dividend Chart

*Amounts are shown in the stock exchange currency (KRW) for convenience

Boryung(KRX-003850) Dividend History

Boryung (KRX-003850) currently pays an annual dividend of $100.00 per share, offering a dividend yield of 1.18%. The next dividend payout date has not been announced.
Ex-Dividend Date Adj. Amount Record Date Pay Date Change (%)
2024 ₩100 0%
12/27/2024 ₩100 12/31/2024 04/30/2025 0%
2023 ₩100 0%
12/27/2023 ₩100 12/31/2023 04/25/2024 0%
2022 ₩100 0%
12/28/2022 ₩100 12/31/2022 04/11/2023 0%
2021 ₩100 20%
12/29/2021 ₩100 12/31/2021 04/12/2022 20%
2020 ₩83.33
12/29/2020 ₩83.33 12/31/2020 04/14/2021
*Amounts are shown in the stock exchange currency (KRW) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.